- Vouliez-vous dire
- supplement,p.
Résultats de la recherche - 7 results
Antibiotic consumption patterns in older adults: a comparative study of people 65 years and older in and outside nursing homes, Belgium, 2016 to 2022.
provide a blueprint for establishing surveillance of NH AMC, based on national reimbursement data.MethodsThe National Institute for Health and Disability Insurance supplied reimbursement AMC data for ...
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
Shendure; Vitali Sintchenko; Alex Sloutsky; Grace E. Smith; Matthew Snyder; Karine Soetaert; Angela M. Starks; Supply, Philip; Suriyapol, Prapat; Sabira Tahseen; Patrick Tang; Teo, Yik-Ying; Thuong N.T. ...
Developments and trends on drugs 2015. Synthesis report by the Belgian Reitox National Focal Point
(2016) Accession Number: D/2016/2505/05 Keywords: demand harm reduction illicit substances prevention supply treatment use Health Topics: Illicit drugs Drogues illégales Illegale drugs Health and disease ...
Belgian national report on drugs 2014. New Development, Trends and in-depth information on selected issues.,
L. Casero Source: wiv-isp, Brussels, p.198 (2015) Accession Number: D/2014/2505/66 Keywords: demand harm reduction illicit substances prveention supply treatment use Health Topics: Illicit drugs ...
From multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study.
Publication Type: Peer reviewed scientific article Authors: Stoffels, Karolien; Allix-Béguec, Caroline; Groenen, Guido; Wanlin, Maryse; Berkvens, Dirk; Vanessa Mathys; Supply, Philip; ...
Socio-economic differences in the utilisation of health services in Belgium.
way. Patient factors may be more important than supply factors in explaining the differential use of health services. Further research needs to focus on socio-economic differences in the reasons, the ...
Batch release of vaccines in Europe: from method transfer to first commercial batch available on the market. Straightforward approach that requires a proactive mindset of the manufacturer.
product specifications or on relevant batch record data (which are usually supplied in section 3 of the protocol). Important modifications of the manufacturing and testing procedures, changes in reagents ...